Measles Immunity Test $35.00
Categories: Most Popular
The Measles Immunity Assessment encompasses 1 test with 1 biomarker.
Overview
The Measles Antibody Quantification, frequently referred to as the Measles Immunity Evaluation, is a blood test that quantifies the presence of antibodies specifically combatting the measles virus within the bloodstream. It is instrumental in verifying a person’s immune defense against measles and in gauging the adequacy of their protection from the virus.
Commonly Referred to As
Rubeola Immunity Test, Measles Virus Immunity Assessment, Measles Antibody Level
Method of Collection
Venipuncture
Type of Sample
Blood serum
Pre-test Requirements
Fasting or special preparation is not necessary
Typical Turnaround Time
Approximately 2-3 business days
When is the Test Requested?
Immune Status Verification
This test is frequently administered to verify whether an individual has immunity against measles, particularly for those who may not have been vaccinated or whose vaccination records are not clear. The assessment determines the existence of antibodies indicative of protection from the virus.
Post-Vaccination Evaluation
The Measles IgG Antibody Quantitative Test is often conducted following vaccination to assess the body’s response and confirm the development of adequate immunity.
Disease Diagnosis Support
In instances where there is a clinical suspicion of measles infection, this test is utilized to support the diagnosis by identifying measles-specific antibodies in the blood.
A Measles IgG Antibody blood test is targeted at detecting IgG antibodies that are produced in response to a measles infection. These antibodies are a part of the immune system’s defense and are an indicator of either past exposure to the virus or the successful vaccination against it.
Measles and mumps, which are both members of the Paramyxoviridae family, typically cause self-limiting diseases that resolve within a few days. However, in certain cases, these viruses can lead to severe health complications. Vaccination has proven e[ective in preventing these diseases, and antibody testing for measles and mumps can confirm whether someone has developed immunity through infection or immunization. Additionally, diagnostic methods like culture or polymerase chain reaction (PCR) can directly identify the virus or its genetic components from patient samples, allowing for a range of diagnostic possibilities.
The introduction of widespread immunization strategies has significantly lowered the incidence of measles and mumps in the U.S., transitioning from hundreds of thousands of cases annually to just a few hundred. The decrease is largely attributed to the success of vaccines and the use of combination vaccines like the MMR, which simultaneously protect against measles, mumps, and rubella.
Measles, also known as rubeola, is a highly infectious disease transmitted via respiratory droplets. Symptoms typically include a high fever, conjunctivitis, cough, photophobia, sore throat, coryza, Koplik spots in the mouth, and a characteristic rash that spreads from the face to the rest of the body. While most individuals recover within several weeks, complications can occur, particularly in those who are malnourished, vitamin A deficient, or immunocompromised. Pregnant women infected with the measles virus are at a higher risk for miscarriage or premature labor.
The global impact of measles remains a concern, especially in under-five mortality, despite significant progress due to vaccinations. In 2013, WHO estimated approximately 145,700 global deaths due to measles, primarily among young children. The United States declared the elimination of endemic measles in 2000 following successful vaccination campaigns. Nonetheless, sporadic outbreaks still arise, predominantly among unvaccinated individuals, often linked to international travel.
The Centers for Disease Control and Prevention (CDC) reported 911 measles cases from 63 outbreaks in the U.S. between 2001 and 2011, with a significant spike in 2014, marking the highest number of cases in two decades. Many cases were associated with travelers from regions experiencing substantial outbreaks.
The persistence of measles globally and the occurrence of outbreaks stress the continuous need for vigilance and immunization e[orts, especially in the face of international travel and the presence of unvaccinated populations.
Associated Tests
- Measles Antibody IgM Evaluation
- Mumps Antibody Determination
- Rubella Antibody Screening
- Varicella Zoster Virus Immunity Check
- Tuberculosis Testing
- Hepatitis B Surface Antigen and Antibody Profiling
- Hepatitis C Antibody Detection
Clinical Contexts
Immunity Status Verification
For individuals lacking documentation of measles vaccination or uncertain of their vaccination status, the Measles Antibody IgG Evaluation helps verify the presence or absence of immunity to the measles virus.
Post-Vaccination Immunity Confirmation
The assessment serves to confirm the immunogenic response following measles vaccination, ascertaining the development of protective antibodies.
Diagnostic Confirmation
When clinical symptoms raise suspicion of measles, this test is pivotal in confirming the diagnosis by detecting measles-specific antibodies.